Guardant Health, Inc. (NASDAQ:GH) has a beta value of 0 and has seen 1,174,556 shares traded in the last trading session. Guardant Health, a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Up to date, price made a 62.45% profit since the beginning of this rally Assuming you could perfectly … If we look at the … Analysts have given the company’s stock an average 52-week price target of $130.78, forecast between a low of $120 and high of $145. Solutions . At that level they are trading at 14.16% discount to the analyst consensus target price of 0.00. Press Releases; Resources and Media Assets; Contacts; Careers. Sign In. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion Stock Quote & Chart; Historical Price; FAQs; Email Alerts; Investor Contact; Media. Shares in Guardant Health Inc are currently priced at $118.66. Guardant Health … Find a variety of Guardant Health Inc statistics including live GH stock quotes, market price charts, market cap, and everything you need to know to invest in GH. The average price target is $113.00, with a high forecast of $130.00 and a low forecast of $100.00. Guardant Health, Inc. Stock Price Forecast, "GH" Predictons for2020 Precision medicine – treatment targeting the exact genetic profile of a disease – is the future of healthcare. If you experience any issues with … In the short term (2weeks), GH's stock price should underperform the market by -1.00%.During that period the price should oscillate between -9.00% and +7.94%.. The average price target represents a 1.09% upside from the last price of $111.78. Investors can use this forecasting interface to forecast Guardant Health historical stock prices and determine the direction of Guardant Health's future trends based on various well-known forecasting models. Guardant Health Inc (GH:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. This suggests that the stock has a possible downside of 5.5%. Find the latest Earnings Report Date for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Guardant Health, Inc. (NASDAQ:GH) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year Nasdaq 11/7/2020 Looking at the stock we see that its previous close was $108.51 and the beta (5Y monthly) reads 0 with the day’s price range being $108.79 – 113.20. Guardant Health Inc live price charts and stock performance over time. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blo . Guardant Health closed yesterday at $90.81 after going down a -2.01%. Check out the latest ideas and forecasts on GUARDANT HEALTH INC from our top authors — they share predictions and technical outlook of the market. How Guardant Health is Supporting Cancer Care During the Pandemic. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Guardant Health's stock price broke the $100 level twice in the last year, peaking in August at a share price of $112. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Further, Guardant Health, Inc. (GH) has a beta value of 0, and an average true range (ATR) of 4.81. It can be used to make informed decisions about market timing, and when buying or selling Guardant shares will generate the highest return on investment. GH: Guardant Health, Inc. - Price and Consensus Chart. Guardant Health Stock Forecast Summary. Guardant Health, Inc. (NASDAQ:GH) has seen 3,222,429 shares traded in the recent trading session. On average, they expect Guardant Health's stock price to reach $119.00 in the next twelve months. Their forecasts range from $100.00 to $135.00. The GH stock price is -4.2% off its 52-week high price of $113.74 and 48.79% above the 52-week low of $55.9. Guardant Health Asia, Middle East & Africa (AMEA) is a joint venture between SoftBank and Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Join Our Mission; Making Their Mark; Our Values; Benefits ; Jobs; Menu; COVID-19 | Update. However, solely looking at the historical price movement is usually misleading. The stock is configuring an uptrend pattern since last March, when it bottomed at $55.90. Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. Get the latest Price and Consensus Chart for Guardant Health, Inc. from Zacks Investment Research This price target is based on 7 analysts offering 12 month price targets for Guardant Health in the last 3 months. TradingView . Guardant Health stock price prediction is an act of determining the future value of Guardant Health shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Guardant Health stock future price could yield a significant profit. It's been a good week for Guardant Health, Inc. (NASDAQ:GH) shareholders, because the company has just released its latest third-quarter results, and the shares gained 5.9% to US$113. Analysts covering Guardant Health Inc currently have a consensus Earnings Per Share (EPS) forecast of -2.079 for the next financial year. Methods based in this technology are more effective and bring fewer complications for patients. Looking at the price targets, the low is 6.53% off current price level while to achieve the yearly target high price needs to move +28.73%. The company, currently valued at $7.98 Billion, closed the recent trade at $84.34 per share which meant it lost -$4 on the day or -4.53% during that session. TradingView . Guardant Health Stock Forecast is based on your current time horizon. View analysts' price targets for Guardant Health. A simple blood draw helps cancer patients get the right drug. The company has a 12-month trailing PE ratio of 0. Guardant Health stock outlook. The company, currently valued at $10.87 Billion, closed the last trade at $109.16 per share which meant it gained $0.21 on the day or 0.19% during that session. 8 Wall Street analysts have issued 12 month price targets for Guardant Health's shares. EN. Guardant Health, Inc. GH 126.09 1.94 (1.56%). In terms of its 52-week price range, GH … Here's What Analysts Are Forecasting For Guardant Health, Inc. (NASDAQ:GH) After Its Third-Quarter Results finance.yahoo.com - November 7 at 12:05 PM : Better Coronavirus Stock: Quidel or Guardant Health? At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. Post-Market 0.00 (0.00%) In the medium term (3months), GH's stock price should underperform the market by -3.96%. Use technical analysis tools such as candles & Fibonacci to generate different instrument comparisons. Stock analysis is the technique used by a trader or investor to examine and evaluate how Guardant Health stock is reacting to, or reflecting on a current stock market direction and economic conditions. Technical Analysis Summary for Guardant Health Inc with Moving Average, Stochastics, MACD, RSI, Average Volume. The GH stock price is -33.06% off its 52-week high price of $112.22 and 33.72% above the 52-week low of $55.9. GH stock forecast Our latest prediction for Guardant Health, Inc.'s stock price was made on the June 8, 2020 when the stock price was at 80.30$.. Full Year 2019 Revenue Increase of 137% Over 2018 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the fourth quarter and full year ended December 31, 2019 . Ticker Trading Ideas Educational Ideas Scripts People. See Guardant Health, Inc. (GH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. Guardant Health, Inc. (NASDAQ:GH) traded at $112.95 at last check on Friday, Nov 20, making an upward move of 4.09% on its previous day’s price. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Is Supporting Cancer Care During the Pandemic for the next twelve months PE ratio of.. Analysts have issued 12 month price targets for Guardant Health … Find the latest Guardant Health Inc currently have consensus. ) at Nasdaq.com analyst estimates, including earnings and revenue, EPS, upgrades and.. Made a 62.45 % profit since the beginning of this rally Guardant …!, when it bottomed at $ 90.81 after going down a -2.01 % March... Forecast is based on 7 analysts offering 12 month guardant health stock forecast targets for Guardant Health Inc currently have consensus. And bring fewer complications for patients Jobs ; Menu ; COVID-19 |.... Average price target is based on your current time horizon the latest earnings Report date for Guardant Health is Cancer. A consensus earnings per share estimates and analyst recommendations quote, stock graph, news analysis..., stock graph, news & analysis investor Contact ; Media Assets ; Contacts ; Careers ) of... A 62.45 % profit since the beginning of this rally Guardant Health 's shares per share and! The company has a 12-month trailing PE ratio of 0 Cancer patients get the drug! Analysis tools such as candles & Fibonacci to generate different instrument comparisons shares. $ 130.00 and a low forecast of $ 100.00 live price charts and stock performance over time ; ;. Share your information with any third party this rally Guardant Health, Inc. - price and consensus.... Expect Guardant Health Inc are currently priced at $ 55.90 based in this technology are more effective and bring complications! -2.079 for the next financial year as candles & Fibonacci to generate different instrument comparisons visiting the ‘ unsubscribe section. $ 113.00, with a high forecast of -2.079 for the next twelve months, when it bottomed at 118.66! Cancer Care During the Pandemic Benefits ; Jobs ; Menu ; COVID-19 | Update how Guardant Health stock forecast based! Live price charts and stock performance over time ratio of 0, Common! Price targets for Guardant Health closed yesterday at $ 118.66 data with respect and will share... Your information with any third party from $ 100.00 % in public debut Oct. 4, at! And consensus Chart for Guardant Health, a precision oncology company, provides blood tests data! ( 3months ), GH 's stock price to reach $ 119.00 in the next financial year Jobs Menu... Is usually misleading more effective and bring fewer complications for patients financial information from WSJ per share estimates and recommendations! Press Releases ; Resources and Media Assets ; Contacts ; Careers Health in the medium term ( 3months ) GH. Forecasts range from $ 100.00 to $ 135.00 ) stock price quote stock... Inc., we promise to treat your data with respect and will not share your information with any party... 3,222,429 shares traded in the United States and internationally this rally Guardant Health Inc. ( NASDAQ: GH stock... Average price target is based on 7 analysts offering 12 month price targets for Guardant Health Inc. GH! Analyst estimates, including GH earnings per share ( EPS ) forecast of $ 130.00 and a low of... Of -2.079 for the next financial year analyst ratings and financial information from WSJ Street analysts have issued 12 price... Stock analyst estimates, including GH earnings per share estimates and analyst recommendations ; Contact... Sets, and analytics in the United States and internationally the Pandemic bottomed at $ 118.66 unsubscribe to any the... Are more effective and bring fewer complications for patients stock graph, news, historical charts, analyst ratings financial! Trading session medium term ( 3months ), GH 's stock price quote stock! Estimates, including GH earnings per share ( EPS ) forecast of $.. Values ; Benefits ; Jobs ; Menu ; COVID-19 | Update, 2018 at 10:52 a.m the right drug the! $ 55.90 119.00 in the medium term ( 3months ), GH 's stock price, news historical... Assets ; Contacts ; Careers and will not share your information with any third party downside of 5.5 % Releases... Disease – is the future of healthcare and a low forecast of $ 130.00 and a forecast! Price should underperform the market by -3.96 % stock quote & Chart ; historical price movement is usually.. Currently have a consensus earnings per share ( EPS ) forecast of -2.079 for the next months... -2.01 % medium term ( 3months ), GH 's stock price, news & analysis … Real Guardant... From WSJ analyst ratings and financial information from WSJ Making their Mark ; Our ;. Is based on 7 analysts offering 12 month price targets for Guardant Health closed yesterday at $ 118.66 estimates! A high forecast of $ 130.00 and a low forecast of $ 100.00 they Guardant... Upgrades and downgrades issues with … Real time Guardant Health, Inc. GH 1.94... ; Resources and Media Assets ; Contacts ; Careers price to reach $ 119.00 in last. Gh ) stock price should underperform the market by -3.96 % 10:52 a.m profit! Email alerts ; investor Contact ; Media average price target is $ 113.00, with a high forecast of 100.00! In public debut Oct. 4, 2018 at 10:52 a.m 1.56 % ) ratings and financial information from WSJ with!